Home
C the Signs

C the Signs Market Share Analysis for February 2026

Discover how C the Signs integrates seamlessly with EMIS and SystmOne to help GPs detect cancer earlier, speed up referrals, and save lives through AI-powered early diagnosis.

Industry: N/A

Domaincthesigns.com

Year Founded2017

Employees51 - 200

Annual Revenue--

C the Signs

C the Signs (including company regionals)

cthesigns.com

See more website traffic and engagement information

Total visits to C the Signs's top domains

Understand C the Signs market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

cthesigns.com5.9K

See more with Sales Intelligence

Avg. visit duration in C the Signs's top domains

Analyze C the Signs engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

cthesigns.com00:00:25

See more with Sales Intelligence

Avg. pageviews on C the Signs's top domains

See how C the Signs keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

cthesigns.com1.74

See more with Sales Intelligence

C the Signs top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by C the Signs

These are the website technologies, by industry, used by C the Signs top domains

Mobile (3)

Meta Viewport

Content Management System (2)

WebFlow

Email Services (2)

G Suite

Marketing (2)

Google Marketing Platform

More Technologies

3

See all

News & Signals from C the Signs

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAstraZeneca plc partners with The Signs Limited.Delivered in partnership between AstraZeneca, C the Signs, NHS Suffolk and North East Essex Integrated Care Board, Health Innovation East and GP Primary Choice, the programme represents the first time in England that population-level, AI-driven case finding has been implemented in primary care for Oesophageal and stomach cancers.

NewsKhosla Ventures invested into The Signs Limited $8M in investment on Jan 4th '25.C the Signs Ltd. recently received a capital injection of $8 million from Khosla Ventures to expand its AI-powered cancer prediction platform to the U.S. market.

NewsThe Signs Limited receives financing of $8M in funding.C the Signs, a London, UK-based creator of an Artificial Intelligence (AI)-based platform to identify patients at risk of cancer at the earliest and most curable stage, raised $8M in funding.